Skip to main content
Clinical Trials/NCT03454464
NCT03454464
Unknown
Not Applicable

To Evaluate the Practicable, Thoroughness and Clinical Value of Bilateral Central Compartment Dissection While Preserve Contrary Thyroid Glands

Fujian Medical University1 site in 1 country100 target enrollmentJanuary 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thyroidectomy
Sponsor
Fujian Medical University
Enrollment
100
Locations
1
Primary Endpoint
number of the lymph node
Last Updated
7 years ago

Overview

Brief Summary

In accordance with the current guidelines,papillary thyroid microcarcinoma such as turmo invasive nerve or trachea, requires total thyroidectomy for follow-up iodine-131 treatment.In the course of clinical work, if the patient can achieve R0 resection, most of the patients do not need iodine-131 treatment,Therefore, there is no need to continue total thyroidectomy.To evaluate the practicable, thoroughness and Clinical value of bilateral central compartment dissection while preserve contrary thyroid glands.

Detailed Description

In accordance with the current guidelines,papillary thyroid microcarcinoma such as turmo invasive nerve or trachea, requires total thyroidectomy for follow-up iodine-131 treatment.In the course of clinical work, if the patient can achieve R0 resection, most of the patients do not need iodine-131 treatment,Therefore, there is no need to continue total thyroidectomy.This study assesses new procedures by adjusting the sequence of procedures. complications and the thoroughness of the operation were evaluated, thus Clinical value of bilateral central compartment dissection with preserve contrary thyroid glands were ananlyed.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
December 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fujian Medical University
Responsible Party
Principal Investigator
Principal Investigator

Bo Wang,MD

Clinical professor

Fujian Medical University

Eligibility Criteria

Inclusion Criteria

  • Tumor diameter less than 1cm The tumor is located in the lower part of the gland No lateral cervical lymph node metastases Traditional open surgery

Exclusion Criteria

  • Select the endoscopic surgery or robotic surgery patients Tumor invades the surrounding trachea and esophagus Patients refused to participate

Outcomes

Primary Outcomes

number of the lymph node

Time Frame: 2 day post operation

the number of the lymph node

The weight of the central compartment tissue.

Time Frame: introoperation

The weight of the central compartment tissue.

number of postive lymph node

Time Frame: 2 day post operation

The number of postive lymph node

Secondary Outcomes

  • thyroid volume(The day before the operation)
  • recurrent laryngeal nerve palsy(1 day ,2weeks,3months,6months post operation)

Study Sites (1)

Loading locations...

Similar Trials